Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    February 2017
  1. STEGMAYR C, Oliveira D, Niemietz N, Willuweit A, et al
    Influence of bevacizumab on blood-brain barrier permeability and O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.187047. doi: 10.2967/jnumed.116.187047.
    PubMed     Text format     Abstract available


    November 2016
  2. WONG FC
    Brain Tumor Imaging.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.186957.
    PubMed     Text format    


    October 2016
  3. MICHELHAUGH SK, Muzik O, Guastella AR, Klinger NV, et al
    Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and alpha-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.179994.
    PubMed     Text format     Abstract available


  4. JANSEN M, Veldhuijzen van Zanten SE, Van Vuurden DG, Huisman M, et al
    Molecular Drug Imaging: 89Zr-bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180216.
    PubMed     Text format     Abstract available


  5. UNTERRAINER M, Galldiks N, Suchorska B, Kowalew LC, et al
    18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.180075.
    PubMed     Text format     Abstract available


    September 2016
  6. LODGE MA, Holdhoff M, Leal JP, Bag AK, et al
    Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178434.
    PubMed     Text format     Abstract available


    July 2016
  7. HUTTERER M, Ebner Y, Riemenschneider MJ, Willuweit A, et al
    Epileptic activity increases cerebral amino acid transport assessed by [18F]-fluoroethyl-L-tyrosine amino acid PET - a potential brain tumor mimic.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176610.
    PubMed     Text format     Abstract available


    June 2016
  8. RADOJEWSKI P, Dumont R, Manrincek N, Brunner P, et al
    Reply: The future of radiopeptide therapy in patients with progressive meningioma.
    J Nucl Med. 2016 Jun 30. pii: jnumed.116.178145.
    PubMed     Text format    


  9. BEHLING K, DiGialleonardo V, Maguire WF, Heeb LE, et al
    Remodelling the vascular microenvironment of glioblastoma with alpha-particles.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173559.
    PubMed     Text format     Abstract available


    April 2016
  10. BEHLING K, Maguire WF, Puebla JC, Sprinkle SR, et al
    Vascular targeted radioimmunotherapy for the treatment of glioblastoma.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.171371.
    PubMed     Text format     Abstract available


  11. HUAILEI J, Bansal A, Pandey M, Peng KW, et al
    Synthesis of 18F-Tetrafluoroborate (18F-TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170894.
    PubMed     Text format     Abstract available


  12. KLETTING P, Kull T, Maass C, Malik N, et al
    Optimized Peptide Amount and Activity for (9)(0)Y-Labeled DOTATATE Therapy.
    J Nucl Med. 2016;57:503-8.
    PubMed     Text format     Abstract available


    March 2016
  13. UNTERRAINER M, Schweisthal F, Suchorska B, Wenter V, et al
    Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma - does it make sense?
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171033.
    PubMed     Text format     Abstract available


    February 2016
  14. SINDONI A
    SOMATOSTATIN RECEPTOR-TARGETED RADIOPEPTIDE THERAPY IN PATIENTS WITH PROGRESSIVE UNRESECTABLE MENINGIOMA.
    J Nucl Med. 2016 Feb 25. pii: jnumed.116.172312.
    PubMed     Text format    


  15. MODAK S, Zanzonico P, Carrasquillo JA, Kushner BH, et al
    Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
    J Nucl Med. 2016;57:231-7.
    PubMed     Text format     Abstract available


    November 2015
  16. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    


  17. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available


    October 2015
  18. ZHANG H, Liu N, Gao S, Hu X, et al
    Can a Novel 18F-ALF-NOTA-PRGD2 PET/CT Predict the Treatment Sensitivity of Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    J Nucl Med. 2015 Oct 29. pii: jnumed.115.165514.
    PubMed     Text format     Abstract available


  19. ZHANG J, Li D, Lang L, Zhu Z, et al
    68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    J Nucl Med. 2015 Oct 8. pii: jnumed.115.165316.
    PubMed     Text format     Abstract available


  20. PERSSON M, Nedergaard M, Brandt-Larsen M, Skovgaard D, et al
    uPAR is a Promising New Imaging Biomarker in Glioblastoma.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.161703.
    PubMed     Text format     Abstract available


  21. HIRATA K, Tamaki N
    uPAR as a Glioma Imaging Target.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.166231.
    PubMed     Text format    


    August 2015
  22. GERSTER-GILLIERON K, Forrer F, Maecke H, Mueller-Brand J, et al
    90Y-DOTATOC as Therapeutic Option for Complex Recurrent or Progressive Meningiomas.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.155853.
    PubMed     Text format     Abstract available


  23. FINK J, Muzi M, Peck M, Krohn KA, et al
    Multi-modality Brain Tumor Imaging - MRI, PET, and PET/MRI.
    J Nucl Med. 2015 Aug 20. pii: jnumed.113.131516.
    PubMed     Text format     Abstract available


  24. MUZI M, Peterson LM, O'Sullivan JN, Fink JR, et al
    18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    J Nucl Med. 2015;56:1223-8.
    PubMed     Text format     Abstract available


    July 2015
  25. HALLE B, Thisgaard H, Hvidsten S, Dam JH, et al
    Estimation of Tumor Volumes by [11C]MeAIB and [18F]FDG PET in an Orthotopic Glioblastoma Rat Model.
    J Nucl Med. 2015 Jul 30. pii: jnumed.115.162511.
    PubMed     Text format     Abstract available


  26. JENSEN P, Feng L, Law I, Svarer C, et al
    TSPO imaging in glioblastoma multiforme: A direct comparison between 123ICLINDE-SPECT, 18F-FET PET and gadolinium-enhanced MRI.
    J Nucl Med. 2015 Jul 16. pii: jnumed.115.158998.
    PubMed     Text format     Abstract available


  27. DEN HOLLANDER MW, Bensch F, Glaudemans AW, Oude Munnink TH, et al
    TGF-beta antibody uptake in recurrent high grade glioma imaged with 89Zr-fresolimumab PET.
    J Nucl Med. 2015 Jul 1. pii: jnumed.115.154401.
    PubMed     Text format     Abstract available


    February 2015
  28. SU Z, Roncaroli F, Durrenberger PF, Coope DJ, et al
    The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: A 11C-(R)PK11195 PET Imaging and Neuropathology Study.
    J Nucl Med. 2015 Feb 26. pii: jnumed.114.151621.
    PubMed     Text format     Abstract available


    January 2015
  29. RACHINGER W, Stoecklein VM, Terpolilli NA, Haug AR, et al
    Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumorfree tissue.
    J Nucl Med. 2015 Jan 29. pii: jnumed.114.149120.
    PubMed     Text format     Abstract available


  30. MARINCEK N, Radojewski P, Dumont RA, Brunner P, et al
    Somatostatin receptor targeted radiopeptide therapy with yttrium-90-DOTATOC and lutetium-177-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.
    J Nucl Med. 2015 Jan 15. pii: jnumed.114.147256.
    PubMed     Text format     Abstract available


  31. USLU L, Donig J, Link M, Rosenberg J, et al
    Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies.
    J Nucl Med. 2015 Jan 8. pii: jnumed.114.146290.
    PubMed     Text format     Abstract available


    December 2014
  32. JANSEN N, Suchorska B, Wenter V, Schmid-Tannwald C, et al
    Prognostic Significance of Dynamic 18F-FET-PET in Newly Diagnosed Astrocytic High Grade Glioma.
    J Nucl Med. 2014 Dec 23. pii: jnumed.114.144675.
    PubMed     Text format     Abstract available


  33. DUNKL V, Cleff C, Stoffels G, Judov N, et al
    The usefulness of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine-PET in the clinical evaluation of brain tumors in children and adolescents.
    J Nucl Med. 2014 Dec 18. pii: jnumed.114.148734.
    PubMed     Text format     Abstract available


  34. COLLAMATI F, Pepe A, Bellini F, Bocci V, et al
    Toward Radioguided Surgery with beta- Decays: Uptake of a Somatostatin Analogue, DOTATOC, in Meningioma and High-Grade Glioma.
    J Nucl Med. 2014 Dec 11. pii: jnumed.114.145995.
    PubMed     Text format     Abstract available


  35. FENG L, Svarer C, Thomsen G, de Nijs R, et al
    In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4'-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamid e SPECT.
    J Nucl Med. 2014;55:1966-72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: